1-20 of 46
Yong-mi Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of Integrin Beta-1 in the Chemoresistance of Acute Myeloid Leukemia

Heather Ogana, Samantha Hurwitz, Zesheng Wan, Hye Na Kim, Samy Jambon, Hisham Abdel-Azim, Miller Huang, Moghimi Babak, Nora Heisterkamp, Anne-Marie Carbonell, Chintan Parekh, Marina Konopleva, Deepa Bhojwani, Yong-Mi Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 8799–8800.
https://doi.org/10.1182/blood-2022-167902
Published: 2022
Journal Articles

TBL1 Inhibitor, Tegavivint, Supresses Cell Survival and Promotes Sensitivity to Chemotherapy in ALL and AML

Samantha Hurwitz, Heather Ogana, Zesheng Wan, Fariba Navid, Deepa Bhojwani, Yong-Mi Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 5995.
https://doi.org/10.1182/blood-2022-167445
Published: 2022
Journal Articles

Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia

Eun Ji Gang, Hye Na Kim, Yao-Te Hsieh, Yongsheng Ruan, Heather A. Ogana, Solomon Lee, Jennifer Pham, Huimin Geng, Eugene Park, Lars Klemm, Cheryl L. Willman, William L. Carroll, Steven D. Mittelman, Etan Orgel, Matthew J. Oberley, Chintan Parekh, Hisham Abdel-Azim, Deepa Bhojwani, Alan S. Wayne, Adèle De Arcangelis, Elisabeth Georges-Labouesse, Elizabeth Wayner, Halvard Bonig, Aspram Minasyan, Johanna ten Hoeve, Thomas G. Graeber, Markus Müschen, Nora Heisterkamp, Yong-Mi Kim
Journal: Blood
Blood (2020) 136 (2): 210–223.
https://doi.org/10.1182/blood.2019001417
Published: 2020
Includes: Supplemental data
Journal Articles

Targeting of Integrin α4/VCAM-1 with AVA4746 Modulates the Redox-Status and Metabolism in ALL and Angiogenesis

Ruan Yongsheng, MD, Enzi Jiang, MD PhD, Hye Na Kim, Heather Ogana, Mo Yang, MD, Deepa Bhojwani, MD, Alan S. Wayne, MD, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3881.
https://doi.org/10.1182/blood-2019-132101
Published: 2019
Journal Articles

Targeting BCL-XL By Protac DT2216 Effectively Eliminates Leukemia Cells in T-ALL Pre-Clinical Models

Qi Zhang, PhD, Sajid Khan, PhD, Xuan Zhang, Vinitha Mary Kuruvilla, MSc, Sanaz Ghotbaldini, Julia Wells, PhD, Natalia Baran, PhDMD, Tianyu Cai, PhD, Lina Han, PhD, Adolfo Ferrando, MD, PhD, Yong-Mi Kim, MD MPH, PhD, Guangrong Zheng, Daohong Zhou, Marina Y Konopleva, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3870.
https://doi.org/10.1182/blood-2019-124744
Published: 2019
Journal Articles

Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for Immunotherapy

Hye Na Kim, Enzi Jiang, MD PhD, Ruan Yongsheng, MD, Heather Ogana, Nour Abdel-Azim, Justin Le, BS, Annie Luong, Halvard Bonig, MD, Nabil Ahmed, MD, Moghimi Babak, MD, Michael A. Pulsipher, MD, Deepa Bhojwani, MD, Alan S. Wayne, MD, Chintan Parekh, MBBS, Hisham Abdel-Azim, Nora Heisterkamp, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2623.
https://doi.org/10.1182/blood-2019-132131
Published: 2019
Journal Articles

Dual Targeting of PI3Kdelta and BRD4 Sensitizes Acute Lymphoblastic Leukemia to Chemotherapy

Hye Na Kim, Cydney Nichols, Enzi Ji Jiang, MD PhD, Nour Abdel-Azim, Ariana Coba, DOnald L. Durden, MD PhD, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1420.
https://doi.org/10.1182/blood-2018-99-116310
Published: 2018
Journal Articles

CAR T Cell Relapse CD19 Negative ALL Cells Express Integrins and Integrin Blockade Can Prolong Survival In Vivo

Hye Na Kim, Solah Lee, Kristen Fousek, BS, MS, Shuangyue Li, Anne Kim, Junji Watanabe, PhD, Halvard Bonig, MD MA, Nabil Ahmed, MD, Hisham Abdel-Azim, Nora Heisterkamp, PhD, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2601.
https://doi.org/10.1182/blood.V130.Suppl_1.2601.2601
Published: 2017
Journal Articles

Integrin alpha6-Deletion Induces Apoptosis and Src Signaling Changes in Acute Lymphoblastic Leukemia Cells

Eun Ji Gang, MD PhD, Hye Na Kim, Johanna Scott, PhD, Matthew J Oberley, MDPhD, Etan Orgel, MD MS, Steven D. Mittelman, MDPhD, Yao-Te Hsieh, PhD, Markus Muschen, MD, Deepa Bhojwani, MD, Daniel Braas, PhD, Thomas Graeber, PhD, Nora Heisterkamp, PhD, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3878.
https://doi.org/10.1182/blood.V130.Suppl_1.3878.3878
Published: 2017
Journal Articles

Targeting Primary Pre-B Cell Acute Lymphoblastic Leukemia and CD19-Negative Relapses Using Trivalent CAR T Cells

Kristen Fousek, BS, MS, Junji Watanabe, PhD, Ann George, PhD, Xingyue An, BS, Hebatalla Samaha, MS, Shoba Alaska Navai, MD, Tiara T Byrd, PhD, Albert Jang, BS, Hye Na Kim, Sujith Joseph, Matthew Baker, Navin Varadarajan, PhD, Meenakshi G. Hegde, MD, Yong-Mi Kim, MD MPH, PhD, Nora Heisterkamp, PhD, Hisham Abdel-Azim, Nabil Ahmed, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4614.
https://doi.org/10.1182/blood.V130.Suppl_1.4614.4614
Published: 2017
Journal Articles

Inhibiting Aurora Kinase B Sensitizes B-Cell Acute Lymphoblastic Leukemia to Glucocorticoids

Coralie Poulard, Hye Na Kim, Celine Gagnieux, Karina Kruth, PhD, Mimi Fang, Daniel Gerke, Deepa Bhojwani, MD, Yong-Mi Kim, MD MPH, PhD, Michael R Stallcup, PhD, Miles A. Pufall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5113.
https://doi.org/10.1182/blood.V130.Suppl_1.5113.5113
Published: 2017
Journal Articles

AVA4746, an Orally Available, Clinical Grade Antagonist of Integrin Alpha 4, Sensitizes Pre-B Cell Acute Lymphoblastic Leukemia to Chemotherapy

Yongsheng Ruan, MD, Eun Ji Gang, Hye-Na Kim, Chintan Parekh, MBBS, Hisham Abdel-Azim, MD, Deepa Bhojwani, MD, Alan S. Wayne, MD, Yong-Mi Kim, MD PhD MPH
Journal: Blood
Blood (2016) 128 (22): 2765.
https://doi.org/10.1182/blood.V128.22.2765.2765
Published: 2016
Journal Articles

Overcoming Drug Resistance of Pre-B ALL Cells By Targeting Integrin alpha6 Associated Cell-Adhesion Mediated Drug Resistance Using a Novel Antibody, P5G10

EunJi Gang, MDPhD, Yao-Te Hsieh, PhD, Hye Na Kim, Yann Duchartre, PhD, Shishido Stephanie, PhD, Markus Muschen, MD, Elizabeth Wayner, PhD, Nora Heisterkamp, PhD, Halvard Bonig, MD MA, Yong-Mi Kim, MDPhDMPH
Journal: Blood
Blood (2015) 126 (23): 2525.
https://doi.org/10.1182/blood.V126.23.2525.2525
Published: 2015
Journal Articles

The PI3Kdelta Inhibitor, CAL-101, Inhibits Migration of Primary Pre-B ALL to SDF1alpha: Treatment Implications for Overcoming Cell-Adhesion-Mediated Drug Resistance

EunJi Gang, MDPhD, Hye Na Kim, Yann Duchartre, PhD, Stephanie Nicole Shishido, PhD, Sajad Khazal, MD, Etai Adam, MD, Nour Abdel-Azim, Chintan Parekh, MBBS, Hisham Abdel-Azim, MD, Deepa Bhojwani, MD, Nora Heisterkamp, PhD, Alan S. Wayne, MD, Yong-Mi Kim, MDPhDMPH
Journal: Blood
Blood (2015) 126 (23): 2526.
https://doi.org/10.1182/blood.V126.23.2526.2526
Published: 2015
Journal Articles

A Novel CD49d Targeting Antisense, ATL1102, Effectively Mobilizes Acute Myeloid Leukemia Cells

Yann Duchartre, PhD, EunJi Gang, MDPhD, Hye Na Kim, Stephanie Nicole Shishido, PhD, Muller Fabbri, MD, Anatoly Grishin, PhD, Chintan Parekh, MBBS, Hisham Abdel-Azim, MD, Deepa Bhojwani, MD, Alan S. Wayne, MD, George Tachas, PhD, Yong-Mi Kim, MDPhDMPH
Journal: Blood
Blood (2015) 126 (23): 3807.
https://doi.org/10.1182/blood.V126.23.3807.3807
Published: 2015
Journal Articles

Megakaryocytes Support Viability Proliferation and Protection of Primary Pre-B ALL Cells from Chemotherapy

Stephanie Nicole Shishido, PhD, EunJi Gang, MDPhD, Ruth Xu, Hye Na Kim, Yann Duchartre, PhD, Steven D. Mittelman, MDPhD, Hisham Abdel-Azim, MD, Matthew J Oberley, MDPhD, Nora Heisterkamp, PhD, Yong-Mi Kim, MDPhDMPH
Journal: Blood
Blood (2015) 126 (23): 3763.
https://doi.org/10.1182/blood.V126.23.3763.3763
Published: 2015
Journal Articles

PI3Kdelta Inhibitor, CAL-101, De-Adheres Primary Pre-B ALL from VCAM-1 and Induces Apoptosis in Primary Pre-B ALL

Sajad Khazal, MD, Enzi Jiang, MD PhD, Stephanie Shishido, Osanna Kosoyan, Kim Hye-Na, Alexa Velasquez, Yao-Te Hsieh, Hisham Abdel-Azim, MD, Ann M Mohrbacher, MD, Akil Merchant, MD, Alan S. Wayne, MD, Nora Heisterkamp, PhD, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2014) 124 (21): 3715.
https://doi.org/10.1182/blood.V124.21.3715.3715
Published: 2014
Journal Articles

VLA4 Blockade In Acute Myeloid Leukemia

Yao-Te Hsieh, Enzi Jiang, MD, PhD, Jennifer Pham, Hye-Na Kim, Hisham Abdel-Azim, MD, Sajad Khazal, MD, Gesine Bug, MD, PhD, Gabriele Spohn, Ph.D., Halvard Bonig, MD, MA, Yong-Mi Kim, MD, MPH, PhD
Journal: Blood
Blood (2013) 122 (21): 3944.
https://doi.org/10.1182/blood.V122.21.3944.3944
Published: 2013
Journal Articles

Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy

Brief Report
Yao-Te Hsieh, Eun Ji Gang, Huimin Geng, Eugene Park, Sandra Huantes, Doreen Chudziak, Katrin Dauber, Paul Schaefer, Carlton Scharman, Hiroyuki Shimada, Seyedmehdi Shojaee, Lars Klemm, Reshmi Parameswaran, Mignon Loh, Eun-Suk Kang, Hong Hoe Koo, Wolf-Karsten Hofmann, Jacob Andrade, Gay M. Crooks, Cheryl L. Willman, Markus Müschen, Thalia Papayannopoulou, Nora Heisterkamp, Halvard Bönig, Yong-Mi Kim
Journal: Blood
Blood (2013) 121 (10): 1814–1818.
https://doi.org/10.1182/blood-2012-01-406272
Published: 2013
Includes: Supplemental data
Journal Articles

The Small Molecule Inhibitor of VLA4 TBC3486 Sensitizes Resistant ALL to Chemotherapy

Yao-Te Hsieh, Eun Ji Gang, MD, PhD, Halvard Bonig, MD, MA, Ronald J Biediger, PhD, Peter Vanderslice, PhD, Yong-Mi Kim, MD, MPH, PhD
Journal: Blood
Blood (2012) 120 (21): 1500.
https://doi.org/10.1182/blood.V120.21.1500.1500
Published: 2012